Literature DB >> 19053324

Bile acids metabonomic study on the CCl4- and alpha-naphthylisothiocyanate-induced animal models: quantitative analysis of 22 bile acids by ultraperformance liquid chromatography-mass spectrometry.

Li Yang1, Aizhen Xiong, Yuqi He, Zaiyong Wang, Changhong Wang, Zhengtao Wang, Wei Li, Ling Yang, Zhibi Hu.   

Abstract

Bile acids (BAs) are crucial for the diagnosis, follow-up, and prognostics of liver and intestinal disorders and other diseases affecting BA metabolism. A rapid, simple, and sensitive analytical method is needed to demonstrate the full metabolic profile and simultaneously determine the individual BAs in biological samples. In our present study, an ultraperformance liquid chromatography-mass spectrometry (UPLC-MS) method has been established and validated for simultaneous quantitation of 22 BAs and a metabonomic study was performed based on the chemometric analysis of the serum samples from carbon tetrachloride (CCl4)- and alpha-naphthylisothiocyanate (ANIT)-induced liver failure rats. The optimal chromatographic condition was effected by UPLC (Acquity UPLC BEH column, 1.7 microm, 2.1 mm x 100 mm) using a linear gradient elution system of methanol-5 mM ammonium acetate containing 0.01% acetic acid after a simple-step deproteinization by precipitation. The separation of the 22 BAs can be finished in less than 12 min, and the concentrations of these BAs in rat serums were simultaneously determined using a selective ions monitoring mode. The method was validated with respect to repeatability (relative standard deviation < 9.78%) and accuracy (relative errors from -13.55 to 9.58%). The range of each BA was found from not detected (nd) to 8301 ng mL(-1), respectively. Furthermore, the developed method was successfully applied to the metabonomics analysis of BAs in CCl4- and ANIT-induced liver failure rats, using principle component analysis and canonical discriminant analysis. The serum samples from the two types of rat liver injury could be distinguished from each other and from the untreated animals according to the varieties of BAs. It indicated that the level of BAs could be considered as a sensitive parameter of hepatotoxicity induced by different chemical toxins. This novel metabonomics study of BAs based on the UPLC-MS profile provides not only an accurate quantitative assay of the serum concentrations of biomarkers but also a promising methodology for evaluation of liver injury.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19053324     DOI: 10.1021/tx800225q

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  28 in total

1.  Evidence That the Length of Bile Loop Determines Serum Bile Acid Concentration and Glycemic Control After Bariatric Surgery.

Authors:  Adriana Mika; Lukasz Kaska; Monika Proczko-Stepaniak; Agnieszka Chomiczewska; Julian Swierczynski; Ryszard T Smolenski; Tomasz Sledzinski
Journal:  Obes Surg       Date:  2018-11       Impact factor: 4.129

2.  A model of in vitro UDP-glucuronosyltransferase inhibition by bile acids predicts possible metabolic disorders.

Authors:  Zhong-Ze Fang; Rong-Rong He; Yun-Feng Cao; Naoki Tanaka; Changtao Jiang; Kristopher W Krausz; Yunpeng Qi; Pei-Pei Dong; Chun-Zhi Ai; Xiao-Yu Sun; Mo Hong; Guang-Bo Ge; Frank J Gonzalez; Xiao-Chi Ma; Hong-Zhi Sun
Journal:  J Lipid Res       Date:  2013-10-10       Impact factor: 5.922

3.  Evaluation of the protective effect of Rhei Radix et Rhizoma against α-naphthylisothiocyanate induced liver injury based on metabolic profile of bile acids.

Authors:  Fan Yang; Ying Xu; Aizhen Xiong; Yugi He; Li Yang; Yu-Jui Yvonne Wan; Zhengtao Wang
Journal:  J Ethnopharmacol       Date:  2012-10-08       Impact factor: 4.360

4.  Liquid chromatography-mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease.

Authors:  Jonathan Barr; Mercedes Vázquez-Chantada; Cristina Alonso; Miriam Pérez-Cormenzana; Rebeca Mayo; Asier Galán; Juan Caballería; Antonio Martín-Duce; Albert Tran; Conrad Wagner; Zigmund Luka; Shelly C Lu; Azucena Castro; Yannick Le Marchand-Brustel; M Luz Martínez-Chantar; Nicolas Veyrie; Karine Clément; Joan Tordjman; Philippe Gual; José M Mato
Journal:  J Proteome Res       Date:  2010-09-03       Impact factor: 4.466

5.  Targeted profiling of circulating and hepatic bile acids in human, mouse, and rat using a UPLC-MRM-MS-validated method.

Authors:  Juan C García-Cañaveras; M Teresa Donato; José V Castell; Agustín Lahoz
Journal:  J Lipid Res       Date:  2012-07-19       Impact factor: 5.922

6.  Rapidly directional biotransformation of tauroursodeoxycholic acid through engineered Escherichia coli.

Authors:  Jie Shi; Jie Wang; Lu Yu; Li Yang; Shujuan Zhao; Zhengtao Wang
Journal:  J Ind Microbiol Biotechnol       Date:  2017-03-22       Impact factor: 3.346

Review 7.  Sandwich-Cultured Hepatocytes as a Tool to Study Drug Disposition and Drug-Induced Liver Injury.

Authors:  Kyunghee Yang; Cen Guo; Jeffrey L Woodhead; Robert L St Claire; Paul B Watkins; Scott Q Siler; Brett A Howell; Kim L R Brouwer
Journal:  J Pharm Sci       Date:  2016-02       Impact factor: 3.534

Review 8.  Bile acids: analysis in biological fluids and tissues.

Authors:  William J Griffiths; Jan Sjövall
Journal:  J Lipid Res       Date:  2010-01       Impact factor: 5.922

Review 9.  The metabolomic window into hepatobiliary disease.

Authors:  Diren Beyoğlu; Jeffrey R Idle
Journal:  J Hepatol       Date:  2013-05-25       Impact factor: 25.083

10.  Comparative Studies on Multi-Component Pharmacokinetics of Polygonum multiflorum Thunb Extract After Oral Administration in Different Rat Models.

Authors:  Ninghui Ma; Yong Zhang; Liyan Sun; Yuan Zhao; Yue Ding; Tong Zhang
Journal:  Front Pharmacol       Date:  2021-06-17       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.